Publication

Human Papillomavirus vaccination in HIV-infected women: need for increased coverage

Authored by:

Kojic, E.M., Rana, A.I., and Cu-Uvin, A.

Full Citation:

Kojic, E.M., Rana, A.I., and Cu-Uvin, A. 2016. Human Papillomavirus vaccination in HIV-infected women: need for increased coverage. Expert Review of Vaccines. 15(1).

View Publication

Additional key concepts from this publication:

Those with HIV are at an increased risk of vaccine-preventable diseases.

Key Evidence: Human Papillomavirus (HPV) infections are more prevalent and persistent in HIV-infected individuals — HPV prevalence rates of 76% in HIV-infected women compared to the 46% prevalence rate in HIV-uninfected women. Cervical prevalence rates are also higher in HIV-infected women — between 48-73% in case compared to 28% in HIV-uninfected women. Additionally, HPV infections and HPV-associated diseases appear to exert a disproportionately higher burden of disease in HIV-infected women as opposed to HIV-uninfected women.